(Q61625049)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10717111%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Results of concomitantly administered chemoradiation for locally advanced noninflammatory breast cancer (English)

0 references

Results of Concomitantly Administered Chemoradiation for Locally Advanced Noninflammatory Breast Cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10717111%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

1

Christine D. Berg

0 references

Sandra M. Swain

series ordinal

2

object named as

Sandra M. Swain

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10717111%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

Berg CD

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10717111%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

October 1994

0 references

1 October 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10717111%20AND%20SRC:MED&resulttype=core&format=json

Seminars in Radiation Oncology

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10717111%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10717111%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10717111%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

226-235

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10717111%20AND%20SRC:MED&resulttype=core&format=json

Combination chemotherapy with mastectomy or radiotherapy for stage III breast carcinoma: a Cancer and Leukemia Group B study

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2805%2980093-1

7 January 2021

Prognostic factors in locally advanced noninflammatory breast cancer. Long-term results following primary chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2805%2980093-1

7 January 2021

Local regional effectiveness of surgery and radiation therapy in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2805%2980093-1

7 January 2021

Adjuvant postoperative radiotherapy, chemotherapy, and immunotherapy in stage III breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2805%2980093-1

7 January 2021

Adjuvant postoperative radiotherapy, chemotherapy, and immunotherapy in stage III breast cancer. II. 5-year results and influence of levamisole

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2805%2980093-1

7 January 2021

Adjuvant chemo- and hormonal therapy in locally advanced breast cancer: a randomized clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2805%2980093-1

7 January 2021

Locally advanced breast cancer: the contribution of cytotoxic and endocrine treatment to radiotherapy. An EORTC Breast Cancer Co-operative Group Trial (10792)

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2805%2980093-1

7 January 2021

Adjuvant chemotherapy (CMF) for stage III breast cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2805%2980093-1

7 January 2021

Subclavicular biopsy as a guideline for the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2805%2980093-1

7 January 2021

Tamoxifen versus chemotherapy as adjuvant treatment in stage III breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2805%2980093-1

7 January 2021

Neoadjuvant chemotherapy or chemotherapy and endocrine therapy in locally advanced breast carcinoma. A prospective, randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2805%2980093-1

7 January 2021

Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2805%2980093-1

7 January 2021

Combined chemotherapy and radiotherapy for locally advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2805%2980093-1

7 January 2021

Surgical adjuvant chemotherapy of metastatic murine tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2805%2980093-1

7 January 2021

Dose-response effect of adjuvant chemotherapy in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2805%2980093-1

7 January 2021

The impact of primary irradiation treatment of localized breast cancer on the ability to administer systemic adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2805%2980093-1

7 January 2021

Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2805%2980093-1

7 January 2021

Long-term results of post-operative radiation therapy following mastectomy with or without chemotherapy in stage I-III breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2805%2980093-1

7 January 2021

Clinical dosimetry for radiotherapy to the breast based on imaging with the prototype Royal Marsden Hospital CT simulator

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2805%2980093-1

7 January 2021

Three-dimensional photon treatment planning of the intact breast

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2805%2980093-1

7 January 2021

Integration of conservative surgery, radiotherapy, and chemotherapy for the treatment of early-stage, node-positive breast cancer: sequencing, timing, and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2805%2980093-1

7 January 2021

Effect of delay in radiation in the combined modality treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2805%2980093-1

7 January 2021

Management of non-resectable (stage III) breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2805%2980093-1

7 January 2021

Concurrent radiochemotherapy in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2805%2980093-1

7 January 2021

Postmastectomy morbidity after combination preoperative irradiation and chemotherapy for locally advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2805%2980093-1

7 January 2021

The effect of systemic therapy on local-regional control in locally advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2805%2980093-1

7 January 2021

Six-year results of a multimodality treatment strategy for locally advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2805%2980093-1

7 January 2021

Results of neoadjuvant chemotherapy and radiation therapy in the breast-conserving treatment of 250 patients with all stages of infiltrative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2805%2980093-1

7 January 2021

Locally advanced adenocarcinoma of the breast without distant metastasis treated with multimodal therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2805%2980093-1

7 January 2021

Induction chemotherapy followed by breast conservation for locally advanced carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2805%2980093-1

7 January 2021

Feasibility of breast-conservation surgery after induction chemotherapy for locally advanced breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1053-4296%2805%2980093-1

7 January 2021

10.1016/S1053-4296(05)80093-1

Identifiers

DOI

0 references

1 reference